WHIPPANY, N.J., May 20, 2015 (GLOBE NEWSWIRE) -- Pazoo, Inc. (OTC Pinks:PZOO) (German WKN#: A1J3DK), is pleased to announce that wholly-owned subsidiary Harris Lee has gained the exclusive right to operate testing laboratories in the State of Colorado utilizing Steep Hill Labs' highly-rated testing techniques and methodology.
Harris Lee is entering into an agreement in principal with newly formed Harris Lee Colorado, LLC which is in the process of finalizing the in-state residency requirements for operating a testing lab in Colorado, as well as building out a technically strong team in the Denver area. David Cunic, CEO, said in making the announcement, "We are excited to bring our expertise and business vision to Colorado. Our partnership with Steep Hill reinforces that science and technology are foremost in our business plan to ensure a healthy and safe cannabis supply to the citizens of Colorado."
Colorado is the third state in which Pazoo Inc. subsidiaries have created a license relationship with Steep Hill for their testing technology. Agreements have been established with Steep Hill in Nevada, Oregon and now Colorado. Cunic said, "We have had such a great response from growers in each of these states because they know and trust Steep Hill's reputation and expertise. We take very seriously Steep Hill's faith in us and we move forward with this expansion knowing we will benefit greatly from Steep Hill's proprietary science and technology."
In other news, Pazoo Inc. Nevada's subsidiary M.A. & Associates, LLC is hosting a grand opening of their Las Vegas Lab on Wednesday, June 3rd, which includes tours and Pazoo Fest. The first part of Pazoo Fest will be held from 3:30 – 7:00PM at the Laboratory in Las Vegas at 2009 Western Ave and is an open house for everyone. The second half of Pazoo Fest has now been set to begin at 6:00PM and will last until 10:00PM at the New York New York Hotel and Casino. Please RSVP to email@example.com to attend.
ABOUT PAZOO Inc.
Pazoo, Inc., is a company focused on health, wellness and safety. Our focus is to provide best-in-class laboratory testing of cannabis and cannabinoids to protect consumers from impurities, contaminants and other irregularities. Through our wholly-owned subsidiary, Harris Lee, and our partnership with MA & Associates, Pazoo provides industry-leading laboratory testing of cannabis. Harris Lee's and MA's license agreements with Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep Hill's top-rated testing protocols in select markets as we expand throughout the USA. Pazoo's subsidiaries are currently licensed to test cannabis in Nevada, Oregon and Colorado, with other states to come. Additionally, Pazoo delivers a comprehensive array of health and wellness information on its website www.pazoo.com.
ABOUT STEEP HILL LABS Inc.
Founded in California in 2008, Steep Hill is a science and technology firm that has become the industry leader in cannabis testing and analytics. With owned and licensed labs in four U.S. states and plans to add labs in New Mexico, Oregon and possibly Jamaica in 2015, Steep Hill is the largest cannabis lab network in the world. The company pioneered the first medical cannabis potency and microbiological contaminants testing methodology for use in California - the first state to legalize medical cannabis. Steep Hill has since developed a variety of revolutionary cannabis testing products, including QuantaCann™, QuantaCann2™ and GenKit™. Steep Hill provides expert consulting services to many states, countries and municipalities, and the company is developing proprietary genetic testing, mapping and trademark protection services for the industry as well.
Safe Harbor Statement:
This update includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as Pazoo, Inc. or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statement.
CONTACT: For Investor Relations: Taylor Capitol, LLC Phone: 973-351-3868 Email: INVESTOR@PAZOO.COM